| |
So far ArisGen has developed 2 novel, innovative and fully proprietary technologies:
- An advanced delivery solution: ESTERIFICATION - PEGylation for the improvement of bioavailability/half-life of peptides and proteins via reversible ester attachment of biocompatible polymers and bio-functional moeities with or witout linkers
|
2. |
A new versatile and unique FORMULATION strategy for non-invasive buccal and sub-lingual administration of peptide and proteins. The technology is based on new and innovative scientific concepts. |
Technologies
